Zimbabwe to formulate Pharmaceutical Development Strategy
Published By : 17 Dec 2014 | Published By : QYRESEARCH
Zimbabwe is in the process of formulating a pharmaceutical development strategy with the aim of expanding its utilization capacity in terms of the production of medicines, states a progress report based on the implementation of Zim-Asset or Zimbabwe Agenda for Sustainable Socio-Economic Transformation. Approximately EUR 150,000 was set aside to prepare for the technical aspects. The move has been backed by the United Nations Industrial Development Organisation and is aimed at reviving the pharmaceutical industry as well as formulating the development strategy.
Once the pharmaceutical development strategy is developed, the utilization capacity will increase in order to ensure local production of efficacious, affordable, and safe essential medicines in Zimbabwe, the report states.
The process of formulating and implementing the pharmaceutical development strategy is anticipated to start from January next year and will continue for a year.
The move has transpired because many pharmaceutical companies in Zimbabwe have been functioning at a below-capacity rate. One of the major reasons for this is the rise in direct external support from donors towards public health institutions.
Donors have not been supporting local pharma companies and this fact has critically hampered the industry, said general manager of Caps Pharmaceuticals Mr Mujaka in an interview recently. The National Pharmaceutical Company has been appointed by the State that looks into the procurement, storing, and distributing of medical supplies to various public healthcare units across Zimbabwe. The National Pharmaceutical Company has been playing a vital role in supplying good quality and reasonably-priced medicines to public health institutions.